# Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients

> **NCT05277688** · PHASE3 · RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 340 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** adjuvant concurrent chemoradiotherapy
- **RADIATION:** radiotherapy

## Key facts

- **NCT ID:** NCT05277688
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-15
- **Primary completion:** 2025-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 340 (ESTIMATED)
- **Last updated:** 2022-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05277688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05277688, "Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05277688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*